Skip to content
Abierto

Award notice, first published as presolicitation

Lamotrigine Tablets Jubilant Cadista Pharmaceuticals, Inc. Base Ordering Period 6/16/2025 - 6/15/2026

36E79725R0004

Department of Veterans Affairs, Nac Pharmaceuticals. Pharmaceutical Preparation Manufacturing.

Awarded

Jubilant Cadista Pharmaceuticals Inc.

$0.00 obligated so far on USAspending

Description

As published on SAM.gov with the solicitation of November 21, 2024.

Amendment for Lamotrigine IR Tablets

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
KMQQLKRF5ZE5
CAGE
441M0
Vendor location
Yardley, PA
Contract
36E79725D0029
Obligated
$0.00, potential $11,913,264
Actions
6 between April 16, 2025 and August 31, 2026
Competition
Full and Open Competition, 6 offers received
Set-aside reported
No Set Aside Used.
Described as
New Award for Lamotrigine Tablets with Jubilant Cadista. Ordering Period Is June 16, 2025 to June 15, 2026 with Four ONE-YEAR Options.
Match
award number 36E79725D0029 equals the contract number; same awarding office 36E797 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. October 23, 2024

    Presolicitation

    Lamotrigine Immediate Release (IR) Tablets

    Due November 28, 2024 at 3:30 PM EST. SAM.gov, notice fa6212b357f44d18b8c9923b43a86861

  2. November 5, 2024

    Solicitation, originally presolicitation

    Lamotrigine Immediate Release (IR) Tablets

    Due November 21, 2024 at 3:30 PM EST. SAM.gov, notice 35bb8f0d7fd041e5a1102a469c9cc29b

  3. November 21, 2024

    Solicitation

    Lamotrigine Immediate Release (IR) Tablets

    Due December 3, 2024 at 3:30 PM EST. SAM.gov, notice c3a97acac4cc4815b68c4aedac009bfb

  4. April 16, 2025

    Award notice

    Awarded to Jubilant Cadista Pharmaceuticals Inc. Yardley 19067 for $11,913,264. SAM.gov, notice de4845942ecd448ea76aa1c4a1b1904c

Points of contact